Digital Edition

Abstracts Presented at the 2019 AVAHO Annual Meeting

September 20-22, 2019 ► Minneapolis, MI

Fed Pract. 2019 August;36(suppl)

 

Table of Contents

Recommended Reading

Fatal Drug-Resistant Invasive Pulmonary Aspergillus fumigatus in a 56-Year-Old Immunosuppressed Man (FULL)
Federal Practitioner
Ibrutinib tops chlorambucil against CLL
Federal Practitioner
Another study supports safety of 2-cm margins for thick melanomas
Federal Practitioner
SC daratumumab deemed feasible for every multiple myeloma patient
Federal Practitioner
Gaps in patient-provider survivorship communication persist
Federal Practitioner
NOACs benefit early stage chronic kidney disease patients
Federal Practitioner
Ibrutinib-venetoclax found highly active in hard-to-treat CLL
Federal Practitioner
BRCA2 mutations linked to childhood NHL
Federal Practitioner
Cancer survivors face more age-related deficits
Federal Practitioner
Ibrutinib-rituximab induction yields ‘unprecedented’ responses in MCL
Federal Practitioner